Catlin Avery W (CIK 0001255348)

Latest company ownership

Shares held
93,586
Last filed at
Sep 7, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2006Q3 2025Q4
Shares held
4,350
Last filed at
Jun 3, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 11, 2017 May 12, 2017 Corbus Pharmaceuticals Holdings, Inc. Director Buy 91.3 +5,000 11.90% ✗ $30.7K
Nov 22, 2016 Nov 22, 2016 Corbus Pharmaceuticals Holdings, Inc. Director Buy 86.3 +2,000 5.00% ✗ $15.1K
Nov 23, 2015 Nov 25, 2015 Celldex Therapeutics, Inc. CFO Sell 7.5 -25,000 -41.59% ✓ $450K
Aug 18, 2015 Aug 19, 2015 Corbus Pharmaceuticals Holdings, Inc. Director Buy 91.3 +8,212 25.83% ✗ $15.6K
Aug 17, 2015 Aug 18, 2015 Corbus Pharmaceuticals Holdings, Inc. Director Buy 91.3 +11,788 58.94% ✗ $22.8K
Jun 15, 2015 Jun 16, 2015 Celldex Therapeutics, Inc. CFO Sell 7.5 -25,000 -50.39% ✓ $614.8K
Jun 9, 2015 Jun 9, 2015 Corbus Pharmaceuticals Holdings, Inc. Director Buy 95.0 +20,000 100.00% ✗ $62K
Dec 6, 2013 Dec 10, 2013 Celldex Therapeutics, Inc. CFO Sell 17.5 -183,333 -92.85% ✗ $4.5M
Jul 1, 2013 Jul 3, 2013 Celldex Therapeutics, Inc. CFO Buy 82.5 +500 3.67% ✗ $3K
Aug 9, 2011 Aug 10, 2011 Celldex Therapeutics, Inc. CFO Buy 90.0 +2,000 100.00% ✗ $4.8K
Sep 8, 2010 Sep 9, 2010 Celldex Therapeutics, Inc. CFO Buy 90.0 +2,000 100.00% ✗ $7K
Nov 30, 2009 Dec 1, 2009 Celldex Therapeutics, Inc. CFO Buy 90.0 +1,000 100.00% ✗ $4.4K
Jan 2, 2009 Jan 5, 2009 Celldex Therapeutics, Inc. CFO Buy 90.0 +100 100.00% ✗ $673.2
Jul 2, 2007 Jul 2, 2007 Celldex Therapeutics, Inc. CFO Buy 77.5 +500 2.38% ✗ $352.8
Aug 16, 2006 Aug 16, 2006 Celldex Therapeutics, Inc. CFO Buy 90.0 +5,000 31.25% ✗ $6.8K
Jul 3, 2006 Jul 3, 2006 Celldex Therapeutics, Inc. CFO Buy 82.5 +500 3.23% ✗ $684.5